The Clorox Company in the news

Venture Visionary Partners LLC increased its stake in The Clorox Company, which recently announced a $1.25 quarterly dividend and reported Q3 earnings of $1.66 EPS.

Clorox CEO Linda Rendle bought $2.36 million in company stock, amidst financial data showing revenue decline but strong EPS and potentially undervalued stock metrics.

Clorox's legal chief Angela Hilt saw her compensation increase to $6.03 million in fiscal 2026, largely due to a $2.5 million stock award.

Evercore ISI lowered The Clorox Company's price target to $99 from $110, and the company received an AAA ESG MSCI rating.

Clorox Co. stock underperformed its competitors on Thursday, despite recording daily gains.

The Clorox Company's legal chief saw her annual compensation increase to over $6 million due to stock performance.

Clorox's Chief Legal Officer acquired shares from a vested grant, with the company withholding shares for taxes.

Clorox released its FY26 annual report, detailing a pivotal transition year marked by the acquisition of GOJO Industries and ERP system implementation, positioning it for long-term growth.

Colgate-Palmolive exhibits stronger operating momentum, global diversification, and consistent growth compared to The Clorox Company, which faces challenges despite its transformation efforts.

The Clorox Company launched Clorox Purell ProCare, a business-to-business hygiene unit, by merging its CloroxPro division with GOJO, to sell hygiene products to professional and healthcare customers through a shared network.

Clorox launched Clorox Purell ProCare, a new health and hygiene platform integrating CloroxPro and the recently acquired GOJO, offering a wide range of cleaning and hygiene solutions.

Clorox launched its Clorox Purell ProCare health and hygiene platform, integrating CloroxPro with GOJO, to serve professional and healthcare customers, reinforcing its strategic pivot and influencing its investment outlook.

Wells Fargo & Company decreased Clorox's price target to $85.00, while the company's Q1 earnings surpassed analyst estimates, and institutional investors adjusted their holdings.

Clorox Co. stock surpassed its competitors during a strong trading day, backed by data from Dow Jones and FactSet.

Palm Valley Capital Fund sold and repurchased Clorox shares in Q3 2026, attributing its decline to consumer space weakness and noting its brand strength supports borrowing capacity.

Clorox, General Mills, and Constellation Brands have all seen stock drops, but Constellation Brands is best positioned for a high-interest-rate environment due to its debt reduction and strong brand loyalty.

Clorox director Christopher J. Williams received deferred stock units in lieu of fees and through dividend reinvestment.

Clorox faces a class action lawsuit for allegedly selling Mistolin and Lestoil cleaners contaminated with a bacterium after a September recall, with plaintiffs claiming prior knowledge from a 2022 Pine-Sol recall and an inadequate refund process.

BNP Paribas adjusted Clorox's price target to $89 from $96 while keeping a Neutral rating.

Clorox is implementing strategic portfolio actions, innovation, and digital expansion, including the acquisition of GOJO Industries, to enhance brand superiority and improve operational efficiency.